The company has entered into an agreement with Poland based Celon Pharma to develop and market a generic version of GlaxoSmithKline’s Seretide Accuhaler in Europe used for treatment of lung diseases.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
